Evaluate provides a view of the pharmaceutical market through solutions that combine technology, real world data, and analytics to assist in making portfolio decisions in the biopharma industry.

Evaluate

Massive Bioinformatics provides bioinformatics and biotechnology solutions aimed at enhancing the quality of life through innovative products and services, self-described as a team of dedicated scientists and software engineers.

Massive Bioinformatics

Evaluate Pharma & Evaluate Omnium

Evaluate Medtech

EvaluateCustomSolutions

Evaluate provides trusted commercial intelligence and predictive analytics for the pharmaceutical industry. We help our clients to refine and transform their understanding of the past, present and future of the global pharmaceutical market to drive better decisions. 

Evaluate solutions give you the time and confidence to turn understanding into insight, and insight into action:

Evaluate Omnium - provides a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, delivering game-changing insight into pharma asset potential.

EvaluatePharma - the trusted global view of the pharmaceutical market’s past, present and future performance with consensus forecasts to 2026, company financials, pipelines, deals and more. @EvaluatePharma 
 
EvaluateMedTech - tracks, benchmarks, and forecasts global performance for the medical device and diagnostic industry with consensus forecasts to 2024, company financials and more.

Evaluate Custom Solutions -  improve your strategic decision-making with customised solutions and deep insights that draw on our industry expertise and trusted commercial intelligence. 

Explore Evaluate at  www.evaluate.com
Twitter: @EvaluatePharma




Advera Health Analytics

Mercury

Evaluate Ltd

As we launched into 2024, hopes were moderately high for dealmaking and investment in #pharma. What was the score at the halfway point in the year? Our new eBook digs into the detail behind the headline figures of a very bumpy recovery. https://ow.ly/LsAt50STztr

What’s the secret formula for creating the next #pharmaceutical behemoth? https://ow.ly/oJL150SPSXJ

Download Evaluate's latest #eBook and discover whether indication expansion drives revenue growth, the pros and cons of in-house vs. outsourced development, and more.

Missed our webinar about #AI in #pharma forecasting? Fear not, we have a blog post with a few highlights for you. And the webinar featuring J+D Forecasting is available on-demand! https://ow.ly/m8Eq50SSYHR

Screening and valuing #pharma assets can be a thorny path, with so many data points to work through. Evaluate Ltd's solutions provide an accurate, impartial, and timely view of pharma #asset potential. Find out more: https://lnkd.in/eseaFYEz

Missed this? Now's the time to catch up on the latest #pharma forecasts with our World Preview #report. Download the full report here: https://lnkd.in/gMe5hqD7

What’s the secret formula for creating the next #pharmaceutical behemoth? https://lnkd.in/gCusCD2U

Download Evaluate Ltd's latest #eBook and discover whether indication expansion drives revenue growth, the pros and cons of in-house vs. outsourced development, and more.

Metric
Company Name	Evaluate	Massive Bioinformatics
Symbol
MSH ID	COM:EVALUATE	COM:MASSIVEBIOINFORMATICS
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services
Industry	Pharmaceutical Analytics	Biotechnology
Country	US	TR
Stage
Employee Count	195
Website	evaluate.com	massivebioinformatics.com
LinkedIn	evaluatepharma
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

EVAL

COM:EVALUATE

Evaluate

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue